Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Karolína Hronová, Martin Šíma, Svatopluk Světlík, Olga Matoušková & Ondřej Slanař. (2014) Pharmacogenetics and immunosuppressive drugs. Expert Review of Clinical Pharmacology 7:6, pages 821-835.
Read now
Read now
Minoli A Perera. (2010) The missing linkage: what pharmacogenetic associations are left to find in CYP3A?. Expert Opinion on Drug Metabolism & Toxicology 6:1, pages 17-28.
Read now
Read now
Articles from other publishers (18)
Xiaojun Cai, Huizhu Song, Zheng Jiao, Hang Yang, Min Zhu, Chengyu Wang, Dong Wei, Lingzhi Shi, Bo Wu & Jingyu Chen. (2020) Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients. European Journal of Pharmaceutical Sciences 152, pages 105448.
Crossref
Crossref
Jianyu Liu, Dexi Chen, Bo Yao, Ge Guan, Chao Liu, Xinmin Jin, Xin Wang, Peng Liu, Yandong Sun & Yunjin Zang. (2020) Effects of donor–recipient combinational CYP3A5 genotypes on tacrolimus dosing in Chinese DDLT adult recipients. International Immunopharmacology 80, pages 106188.
Crossref
Crossref
Clinton B. Mathias & Jeremy P. McAleer. 2020. Pharmacology of Immunotherapeutic Drugs. Pharmacology of Immunotherapeutic Drugs
251
276
.
Bo Sun, Yankun Guo, Junwei Gao, Weifeng Shi, Guorong Fan, Xiaoyu Li, Jianxin Qiu, Yan Qin & Gaolin Liu. (2017)
Influence of
CYP3A
and
ABCB1
polymorphisms on cyclosporine concentrations in renal transplant recipients
. Pharmacogenomics 18:16, pages 1503-1513.
Crossref
Crossref
Jing ZhangYing Dai, Zhihong LiuMinxin ZhangChen LiDingxiong ChenHongtao Song. (2017) Effect of CYP3A4 and CYP3A5 Genetic Polymorphisms on the Pharmacokinetics of Sirolimus in Healthy Chinese Volunteers. Therapeutic Drug Monitoring 39:4, pages 406-411.
Crossref
Crossref
Loralie Langman, Teun van Gelder & Ron H.N. van Schaik. 2016. Personalized Immunosuppression in Transplantation. Personalized Immunosuppression in Transplantation
109
124
.
Li-Ping Zhou, Fan Yao, Hong Luan, Yin-Ling Wang, Xi-Hua Dong, Wen-Wen Zhou & Qi-Hui Wang. (2012) CYP3A4*1B polymorphism and cancer risk: A HuGE review and meta-analysis. Tumor Biology 34:2, pages 649-660.
Crossref
Crossref
Meghan Brennan, J. Andrew Williams, Ying Chen, Michael Tortorici, Yazdi Pithavala & Yingxue Cathy Liu. (2011) Meta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics. European Journal of Clinical Pharmacology 68:5, pages 645-655.
Crossref
Crossref
P. Stratta, M. Quaglia, T. Cena, R. Antoniotti, R. Fenoglio, A. Menegotto, D. Ferrante, A. Genazzani, S. Terrazzino & C. Magnani. (2011) The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation. European Journal of Clinical Pharmacology 68:5, pages 671-680.
Crossref
Crossref
Zdenek Dvorak. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
223
258
.
Vita Dolžan. 2012. Pharmacogenetics and Individualized Therapy. Pharmacogenetics and Individualized Therapy
13
80
.
D. Olga McDanielTonya ThurberAngela Lewis-TraylorCrystal BerryWilliam Henry BarberXinchun ZhouSteven BiglerRalph Vance. (2023) Differential Association of Cytochrome P450 3A4 Genotypes with Onsets of Breast Tumors in African American versus Caucasian Patients. Journal of Investigative Medicine 59:7, pages 1096-1103.
Crossref
Crossref
X.-J. Shi, F. Geng, Z. Jiao, X.-Y. Cui, X.-Y. Qiu & M.-K. Zhong. (2011) Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis. Journal of Clinical Pharmacy and Therapeutics 36:5, pages 614-624.
Crossref
Crossref
Ana Santoro, Claudia R Felipe, Helio Tedesco-Silva, Jose O Medina-Pestana, Claudio J Struchiner, Elida B Ojopi & Guilherme Suarez-Kurtz. (2011) Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients. Pharmacogenomics 12:9, pages 1293-1303.
Crossref
Crossref
Xiaoqing Zhang, Zhaowen Wang, Junwei Fan, Gaolin Liu & Zhihai Peng. (2011) Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period. European Journal of Clinical Pharmacology 67:8, pages 803-813.
Crossref
Crossref
H J Zhu, S H Yuan, Y Fang, X Z Sun, H Kong & W H Ge. (2010) The effect of CYP3A5 polymorphism on dose-adjusted cyclosporine concentration in renal transplant recipients: a meta-analysis. The Pharmacogenomics Journal 11:3, pages 237-246.
Crossref
Crossref
Robert Vaughan & Steven Sacks. (2010) Genomics in human renal transplantation. Current Opinion in Immunology 22:5, pages 689-693.
Crossref
Crossref
Donald J. AbrahamAnke‐Hilse Maitland‐van der Zee, Brian J. Puckett, Steven G. Terra & Joe Walker. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
181
204
.